Literature DB >> 26031421

Vitamin D Deficiency Associated with Disease Activity in Patients with Inflammatory Bowel Diseases.

Mehdi Torki1,2, Ali Gholamrezaei3,4, Leila Mirbagher5, Manijeh Danesh6, Sara Kheiri7, Mohammad Hassan Emami8,9.   

Abstract

BACKGROUND: Evidence exists on the association between vitamin D deficiency and inflammatory bowel diseases (IBD). AIMS: To investigate whether vitamin D level is associated with disease activity and quality of life in IBD patients.
METHODS: This cross-sectional study was conducted on known adult IBD patients referred to an outpatient clinic of gastroenterology in Isfahan city, Iran. Disease activity was evaluated using the Simplified Crohn's Disease Activity Index and Simple Clinical Colitis Activity Index. Quality of life was assessed with the Short-Inflammatory Bowel Disease Questionnaire. Serum 25[OH]D was measured using the radioimmunoassay method. Vitamin D deficiency and insufficiency were defined as concentration of <50 and 50-75 nmol/L, respectively.
RESULTS: Studied subjects were 85 ulcerative colitis and 48 Crohn's disease patients (54.1% females) with mean age of 42.0 ± 14.0 years. Vitamin D deficiency and insufficiency were present in 52 (39.0%) and 24 (18.0%) patients, respectively. Thirty patients (22.5%) had active disease who, compared with patients in remission, had more frequent low vitamin D levels (80 vs. 50.4%, P = 0.005). Quality of life was not different between patients with low and those with normal vitamin D levels (P = 0.693). In the logistic regression model, low vitamin D was independently associated with active disease status, OR (95% CI) = 5.959 (1.695-20.952).
CONCLUSIONS: We found an association between vitamin D deficiency/insufficiency and disease activity in IBD patients. Prospective cohorts and clinical trials are required to clarify the role of vitamin D deficiency and its treatment in clinical course of IBD.

Entities:  

Keywords:  25-Hydroxyvitamin D; Crohn’s disease; Inflammatory bowel diseases; Quality of life; Ulcerative colitis; Vitamin D

Mesh:

Year:  2015        PMID: 26031421     DOI: 10.1007/s10620-015-3727-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  42 in total

1.  Bone mineral density, vitamin D, and disease activity in children newly diagnosed with inflammatory bowel disease.

Authors:  Wael El-Matary; Sheena Sikora; Donald Spady
Journal:  Dig Dis Sci       Date:  2010-08-20       Impact factor: 3.199

Review 2.  The geoepidemiology of autoimmune intestinal diseases.

Authors:  Ian Logan; Christopher L Bowlus
Journal:  Autoimmun Rev       Date:  2009-11-10       Impact factor: 9.754

3.  Low exposure to sunlight is a risk factor for Crohn's disease.

Authors:  V Nerich; P Jantchou; M-C Boutron-Ruault; E Monnet; A Weill; V Vanbockstael; G-R Auleley; C Balaire; P Dubost; S Rican; H Allemand; F Carbonnel
Journal:  Aliment Pharmacol Ther       Date:  2011-02-20       Impact factor: 8.171

4.  Serum 25-hydroxyvitamin D concentration and inflammatory bowel disease characteristics in Romania.

Authors:  Gabriela Dumitrescu; Catalina Mihai; Mihaela Dranga; Cristina Cijevschi Prelipcean
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

5.  Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes.

Authors:  Alain M Schoepfer; Christoph Beglinger; Alex Straumann; Ekaterina Safroneeva; Yvonne Romero; David Armstrong; Carsten Schmidt; Michael Trummler; Valérie Pittet; Stephan R Vavricka
Journal:  Inflamm Bowel Dis       Date:  2013-02       Impact factor: 5.325

6.  Assessment of the influence of disease activity on the quality of life of patients with inflammatory bowel disease using a short questionnaire.

Authors:  Francesc Casellas; Maria-José Alcalá; Luis Prieto; José-Ramón Armengol Miró; Juan-Ramón Malagelada
Journal:  Am J Gastroenterol       Date:  2004-03       Impact factor: 10.864

7.  Association of circulating vitamin D concentrations with intestinal but not systemic inflammation in inflammatory bowel disease.

Authors:  Mayur Garg; Ourania Rosella; John S Lubel; Peter R Gibson
Journal:  Inflamm Bowel Dis       Date:  2013-11       Impact factor: 5.325

Review 8.  Environmental risk factors for inflammatory bowel diseases: a review.

Authors:  Ashwin N Ananthakrishnan
Journal:  Dig Dis Sci       Date:  2014-09-10       Impact factor: 3.199

9.  Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study.

Authors:  S P Jørgensen; J Agnholt; H Glerup; S Lyhne; G E Villadsen; C L Hvas; L E Bartels; J Kelsen; L A Christensen; J F Dahlerup
Journal:  Aliment Pharmacol Ther       Date:  2010-05-11       Impact factor: 8.171

Review 10.  Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease.

Authors:  Margherita T Cantorna; Kaitlin McDaniel; Stephanie Bora; Jing Chen; Jamaal James
Journal:  Exp Biol Med (Maywood)       Date:  2014-03-25
View more
  25 in total

1.  Important Issues Regarding Serum 25-Hydroxy Vitamin D Measurement in Inflammatory Bowel Disease Patients.

Authors:  Raika Jamali
Journal:  Dig Dis Sci       Date:  2015-08-14       Impact factor: 3.199

Review 2.  ROS in gastrointestinal inflammation: Rescue Or Sabotage?

Authors:  G Aviello; U G Knaus
Journal:  Br J Pharmacol       Date:  2016-03-03       Impact factor: 8.739

Review 3.  Vitamin D/VDR, Probiotics, and Gastrointestinal Diseases.

Authors:  Mei Shang; Jun Sun
Journal:  Curr Med Chem       Date:  2017       Impact factor: 4.530

Review 4.  Modifiable Environmental Factors in Inflammatory Bowel Disease.

Authors:  Kristin E Burke; Christine Boumitri; Ashwin N Ananthakrishnan
Journal:  Curr Gastroenterol Rep       Date:  2017-05

Review 5.  The Role of Vitamin D in Immune System and Inflammatory Bowel Disease.

Authors:  Zengrong Wu; Deliang Liu; Feihong Deng
Journal:  J Inflamm Res       Date:  2022-05-28

6.  Low Serum Vitamin D During Remission Increases Risk of Clinical Relapse in Patients With Ulcerative Colitis.

Authors:  John Gubatan; Shuji Mitsuhashi; Talia Zenlea; Laura Rosenberg; Simon Robson; Alan C Moss
Journal:  Clin Gastroenterol Hepatol       Date:  2016-06-04       Impact factor: 11.382

7.  Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis.

Authors:  Katherine Meckel; Yan Chun Li; John Lim; Masha Kocherginsky; Chris Weber; Anas Almoghrabi; Xindi Chen; Austin Kaboff; Farhana Sadiq; Stephen B Hanauer; Russell D Cohen; John Kwon; David T Rubin; Ira Hanan; Atsushi Sakuraba; Eugene Yen; Marc Bissonnette; Joel Pekow
Journal:  Am J Clin Nutr       Date:  2016-06-08       Impact factor: 7.045

Review 8.  Protective links between vitamin D, inflammatory bowel disease and colon cancer.

Authors:  Stacey Meeker; Audrey Seamons; Lillian Maggio-Price; Jisun Paik
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 9.  Care of inflammatory bowel disease patients in remission.

Authors:  Charumathi Raghu Subramanian; George Triadafilopoulos
Journal:  Gastroenterol Rep (Oxf)       Date:  2016-10-10

10.  Genotype-Phenotype Associations of the CD-Associated Single Nucleotide Polymorphism within the Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 22 in Patients of the Swiss IBD Cohort.

Authors:  Marianne R Spalinger; Jonas Zeitz; Luc Biedermann; Jean-Benoit Rossel; Michael C Sulz; Pascal Frei; Sylvie Scharl; Stephan R Vavricka; Michael Fried; Gerhard Rogler; Michael Scharl
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.